Mobile-Menu

Bayer Aspires to Significantly Expand Life Science Businesses

For Crop Science as a whole, the aim is to achieve above-market growth and raise sales to more than EUR 11 billion in 2017 (2014: EUR 9.5 billion), giving average annual growth of around 5 %. It is intended to maintain the Ebitda margin before special items at an industry-leading level of 23 to 25 % (2014: 24.9 %). (Picture: Bayer Crop Science) arrow back arrow forward Image Zoom
For Crop Science as a whole, the aim is to achieve above-market growth and raise sales to more than EUR 11 billion in 2017 (2014: EUR 9.5 billion), giving average annual growth of around 5 %. It is intended to maintain the Ebitda margin before special items at an industry-leading level of 23 to 25 % (2014: 24.9 %). (Picture: Bayer Crop Science)
3/4
Back to the Article